| Name | Title | Contact Details |
|---|
Corwin Medical Care is a Plainfield, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Herbalife Nutrition is a global company that has been changing people`s lives with great nutrition products and a proven business opportunity for its independent distributors since 1980. The Company offers high-quality, science-backed products, sold in over 90 countries by entrepreneurial distributors who provide one-on-one coaching and a supportive community that inspires their customers to embrace a healthier, more active lifestyle. We have over 9,500 employees worldwide and are traded on the New York Stock Exchange (NYSE: HLF) with net sales of approximately $4.9 billion in 2019. To learn more, visit Herbalife.com or IAmHerbalife.com. Financial information is available on ir.herbalife.com We are also proud to sponsor more than 190 world-class athletes, teams and events around the globe, including Cristiano Ronaldo, the LA Galaxy, and numerous Olympic teams. Through our global campaign to eradicate hunger, we are committed to bringing nutrition and education to communities around the world.
Energist Group is a Nyack, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Bionor Pharma is a leading biotechnology company advancing the first therapeutic vaccine towards a functional cure for HIV. The company`s focus is the research and development of peptide-based vaccines against viral diseases, primarily HIV. Bionor Pharma`s most advanced product candidate is Vacc-4x, which is also the most advanced therapeutic vaccine in the HIV space and has demonstrated a reduction of viral load in a large, randomized, controlled Phase II trial, as well as safety and tolerability. Pharma`s current clinical focus is to explore whether Vacc-4x, used with other medicines as a combination therapy, can reduce the viral load even further, and the company, through collaboration with Celgene, is investigating Vacc-4x and the HDAC inhibitor romidepsin in the REDUC study. In May 2015, Bionor Pharma announced promising results from an interim analysis of Part B of the REDUC study. In the study, Vacc-4x and romidepsin are explored as a possible treatment regimen to reduce the persistent latent viral reservoir in HIV infected patients on anti-retroviral treatment. Results are expected in the second half of 2015. Bionor Pharma is headquartered in Oslo, Norway, with offices in Copenhagen and New York.
Parfums De Coeur Ltd is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Darien, CT. To find more information about Parfums De Coeur Ltd, please visit www.pdcltd.com